# Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction

> **NCT02525718** · PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 47 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Saline
- **DRUG:** 0.25 % bupivacaine (2.5 mg/ml) w/ 1:100,000 epinephrine & 4 mg dexamethasone

## Key facts

- **NCT ID:** NCT02525718
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-11
- **Final completion:** 2017-03
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02525718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02525718, "Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02525718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*